# OnCo record auron-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/auron-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "auron-therapeutics" ;
  schema:name "Auron Therapeutics"@en ;
  schema:description "Auron Therapeutics makes a tablet medicine, AUTX-703, that breaks down two proteins some cancers depend on to stay in an aggressive state. It is in an early trial for acute myeloid leukaemia and myelodysplastic syndrome that has come back or not responded to treatment."@en ;
  schema:url <https://onco.cc/companies/auron-therapeutics/>, <https://aurontx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://aurontx.com/>, <https://aurontx.com/news/auron-announces-first-patient-dosed-in-phase-1-clinical-trial-of-autx-703-in-advanced-hematologic-malignancies>, <https://clinicaltrials.gov/study/NCT06846606> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/prostate-nepc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/ai-computation/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/kat2a/>, <https://onco.cc/targets/kat2b/> .